Medicaid - residential and inpatient substance use disorder services benefit - waiver submission - appropriation. The act adds residential and inpatient substance use disorder services and medical detoxification services to the Colorado medical assistance program. The benefit is limited to persons who meet nationally recognized, evidence-based level of care criteria for residential and inpatient substance use disorder treatment, and covers all levels of care. The benefit will not be effective until the department of health care policy and financing (department) seeks and receives any federal authorization necessary to secure federal financial participation in the program. Prior to seeking federal approval, the department shall seek input from stakeholders regarding decisions relating to the benefit.
The department shall prepare and submit a performance review report to committees of the general assembly concerning services provided under the benefit and the effectiveness of those services. After considering the performance review report, the general assembly may enact legislation modifying or repealing the benefit.
If an enhanced residential and inpatient substance use disorder treatment and medical detoxification services benefit becomes available, managed care service organizations shall determine to what extent money allocated from the marijuana tax cash fund may be used to assist in providing treatment, including residential treatment and medical detoxification services if those services are not otherwise covered by public or private insurance.
For the 2018-19 state fiscal year, the act appropriates $236,827 to the department executive director's office to implement the act. Of this amount, $155,193 is from general fund and $81,634 is from the healthcare affordability and sustainability fee cash fund. The general assembly also anticipates receiving $236,828 in federal funds for use by the executive director's office to implement this act.
(Note: This summary applies to this bill as enacted.)